We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Fluoxetine Ameliorates the Aggravation of UC Symptoms in C57BL/6 Mice Induced by CUMS

    Objective

    Patients with chronic ulcerative colitis (UC) often have mental symptoms such as depression and anxiety, and stress can lead to...

    Teng Zhao, Yu-xin Zhou, ... Zhen-hua Chen in Current Medical Science
    Article 29 August 2023
  2. Fluoxetine

    Article 13 July 2024
  3. The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials

    Background

    Fluoxetine is one of the selective serotonin reuptake inhibitors that can improve motor and function recovery after a stroke. Several...

    Jixiang Wu, Guoyong Qin in International Journal of Clinical Pharmacy
    Article 20 April 2023
  4. Fluoxetine

    Article 06 April 2024
  5. Fluoxetine

    Article 23 March 2024
  6. Fluoxetine

    Article 09 March 2024
  7. Fluoxetine

    Article 21 October 2023
  8. Fluoxetine

    Article 04 November 2023
  9. Fluoxetine

    Article 15 July 2023
  10. Fluoxetine

    Article 30 September 2023
  11. Fluoxetine

    Article 20 May 2023
  12. Fluoxetine improves bone microarchitecture and mechanical properties in rodents undergoing chronic mild stress – an animal model of depression

    Depression is one of the most prevalent mental disorders associated with reductions in bone mineral density and increased fracture risk. Fluoxetine...

    Raymond W. Lam, Hee-Kit Wong, ... Cyrus S. Ho in Translational Psychiatry
    Article Open access 20 August 2022
  13. Fluoxetine

    Article 03 June 2023
  14. Bupropion/fluoxetine

    Article 12 August 2023
  15. Low-dose and repeated exposure to fluoxetine leads to eryptosis and hematological disorder in Wistar rats

    Fluoxetine is an antidepressant that has multiple mechanisms of action and belongs to the group of selective serotonin reuptake inhibitors. The drug...

    Damir Suljević, Maja Mitrašinović-Brulić, ... Muhamed Fočak in Comparative Clinical Pathology
    Article 16 January 2023
  16. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid

    Purposes

    (1) To summarize the mental conditions that may accompany persistent symptoms following acute infection by SARS-CoV-2, often termed Long...

    Jeffrey Fessel in Discover Mental Health
    Article Open access 03 January 2023
Did you find what you were looking for? Share feedback.